Trial Profile
The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC)
Status:
Suspended
Phase of Trial:
Phase I/II
Latest Information Update: 23 Apr 2024
Price :
$35
*
At a glance
- Drugs Umbilical cord mesenchymal stem cell therapy Sclnow Biotechnology (Primary)
- Indications Femur head necrosis; Osteonecrosis
- Focus Therapeutic Use
- Sponsors Sclnow Biotechnology
- 18 Apr 2024 Planned End Date changed from 1 Dec 2024 to 31 Dec 2025.
- 18 Apr 2024 Planned primary completion date changed from 1 Jun 2024 to 30 Jun 2025.
- 18 Apr 2024 Planned initiation date changed from 1 Dec 2023 to 31 Dec 2024.